Navigation Links
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Date:12/2/2008

rd-party reimbursement policies or adverse changes in those policies; any inability by the Company to ship product on a timely basis; the Company's ability to manage its growth; the effects of recent disruptions in global credit and equity markets and other adverse economic developments that could adversely affect the market for our products or our ability to raise needed financing; actions by our competitors; and the Company's ability to protect its intellectual property. Other factors that could cause Cardiogenesis' actual results to differ materially are discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 and the Company's other recent SEC filings. The Company disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.


'/>"/>
SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cardiogenesis Reports Third Quarter 2008 Results
2. Cardiogenesis Reports Fourth Quarter and Full Year 2007 Results
3. Cardiogenesis Corporation to Report Third Quarter 2007 Results on November 14th
4. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
5. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
6. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
7. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
8. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
9. Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria
10. Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference
11. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...Dec. 3 ACCESS PHARMACE...y provided an update on its European commercial la... mucositis, a debilitating side effect of radiatio...ly launched by Access, partner, SpePharm, in six E...y, Norway, Greece and Sweden. Access is conducting...
(Date:12/3/2009)...ass., Dec. 3 Caliper Lif...der of tools and services for drug discovery and l...ge 4.0 software for IVIS® in vivo imaging sys...00 Caliper IVIS systems currently installed in lab...anced spectral unmixing tools to enhance fluoresce...
(Date:12/2/2009)...K, Dec. 2 Reportlinker.com announc...in its catalogue: ,, Carbondioxide Incubators ...eportlinker.com/p0164368/Carbondioxide-Incubators-...ors are the most critical equipment used in microb...ications for providing a controlled environment to...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biote...NASDAQ: ONCY ) announced today that in connection ...nderwriters have exercised in full their over-allo...nits. Each unit is comprised of one common share a... sold at a price of US$3.00 per unit. Each whole c...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...oday announced the,publication of an independent, ...e level of cellular immune response measured prior...prietary ImmuKnow(R) immune cell,function test was...r early,acute transplant rejection and unstable ki...transplantation., The results of this independent...
...ard a U.S. Naval Academy satellite called MidSTAR-...One technology is a sensor that can check for harm...at can control heat. , These technologies were co...e Flight Center, Greenbelt, Md.; NASAs Ames Resear...gy Systems Inc. of various U.S. locations, respect...
...& Lione, one of,the largest intellectual property ...unce that Meredith Martin Addy has been named one ...actice areas by Law & Politics,magazine., Intelle...tionally has,been dominated by men. However, in fo...st recognized patent attorneys in Illinois. In the...
Other Biology Technology:New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3NASA MidSTAR-1 successful technologies may be revolutionary 2NASA MidSTAR-1 successful technologies may be revolutionary 3NASA MidSTAR-1 successful technologies may be revolutionary 4Meredith Martin Addy Named One of Top 10 Illinois 'Super Lawyers' for 2008 2
(Date:12/2/2009)...dhand smoke for a prolonged period of time and in ...er, even in women who never smoked cigarettes them...side-stream smoke could increase risk of breast ca...ds, Ph.D., senior research scientist at the Northe...ile no single epidemiologic study can answer the q...
(Date:12/2/2009)...tter, and other foods have done more than raise pu... also are quietly fueling a boom in the market for...ety regulations. That,s the topic of the two-part ...gineering News , (C&EN) ACS, weekly newsmagazine. ...or Correspondent Marc Reisch point out that food s...
(Date:12/2/2009)...al Center researchers have figured out how stem ce...tter able to resist radiation therapy. And using a...hese cancer stem cells, they were able to kill man... experiment. , The work builds off earlier rese...e effects of radiation much better than other canc...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Discovery makes brain tumor cells more responsive to radiation 2Stemedica Completes Meeting with the FDA 14477 1Stemedica Completes Meeting with the FDA 14477 2Stemedica Completes Meeting with the FDA 14477 3deVere and Partners Raises Funds for Geneva Children in Need 59509 1deVere and Partners Raises Funds for Geneva Children in Need 59509 2deVere and Partners Raises Funds for Geneva Children in Need 59509 3New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 1New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 2
...ified another anti-cancer effect of the "longevity...e tumor promoter c-Myc, SIRT1 curbs cell division.....jcb.org ) and will appear in the April 20 print i...st and nematode equivalents of SIRT1 are fountains...ws aging in mammals isn,t certain, but it,s benefi...
...human and mouse, two groups of researchers have co... is associated with progressive hearing loss. The ...of RNA that affects the production of hundreds of ...nner ear. , The research provides important new ...n in humans but remains poorly understood. , One ...
...ntially catastrophic damage, for example as a resu...ke a decision: either to fix the damage or program... , It,s a stark decision that is as mysterious a...bed metaphorically as a network of internal alarms...ell nucleus. In intricate ways, cells orchestrate...
Other Biology News:New insights into progressive hearing loss 2New insights into progressive hearing loss 3New insights into progressive hearing loss 4CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 2CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 4
Eppendorf Thermomixer R from Eppendorf North America
BD BioCoat Laminin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Matrigel Matrix 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Fibronectin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: